Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Type 2 Diabetes
- Canagliflozin May Reduce Cardiovascular Events in Type 2 Diabetes
- Racial Differences in the Relationship of Glucose Concentrations and HbA1c Levels
- Heart Rate and Rhythm and the Benefit of Beta Blockers in Patients With Heart Failure
- Systolic Blood Pressure Reduction Lowers the Risk of Cardiovascular Disease and Mortality
- Study Finds No Benefit With Statins for Primary Prevention in Older Adults
- SGLT2 Inhibitors and Diabetic Ketoacidosis
- GI Safety of Celecoxib vs Naproxen in Patients With Cardiothrombotic Diseases and Arthritis After Upper GI Bleeding
- Update on the Management of Heart Failure From the ACC/AHA/HFSA
- Sulfonylureas Are Associated With Increased Risks of Cardiovascular Events and Death